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Synthetic peptides of the putative effector domain of members of the rub3 gene family of small GTP-binding proteins have been shown to have 
potent actions on vesicular transport and exocytosis [1,2]. Here, we use similar rab3-effector domain peptides to study their role in intra~llular 
signalling in mast cehs. We find that rab3-like peptides stimulate exocytosis and decrease cyclic 3’,5’-AMP levels in these cells when applied 
extracellularly. Cells pretreated with pertussis toxin (PtX) to selectively uncouple a&, type G proteins from their biological activators, however, 
did not respond to rab3 peptides. rab3-like peptides also induce a Ca*’ transient in mast cells. These observations provide evidence for functional 
coupling between an effector domain peptide sequence of rab3 protein and a PtX-sensitive G protein substrate. 
Exocytosis; rab3; GTP-binding protein; Pertussis toxin; Mast cell 
1. INTRODUCTION 
Synthetic peptides corresponding to a putative effec- 
tor domain of the small GTP binding protein rab3 have 
been shown to stimulate exocytosis from chemically 
permeabilised pancreatic acinar cells [3], adrenal chro- 
maffin cells [4], patch-clamped mast cells 121; and in a 
cell-free assay system between pancreatic zymogen 
granules and plasma membrane [5]. How these peptides 
stimulate xocytosis is unknown but they are commonly 
used as biochemical tools to mimic the role of rab3 
protein inside cells [l-4]. We report here that rab3-like 
peptides stimulate exocytosis from mast cells via a per- 
tussis toxin (PtX) sensitive mechanism. 
2. MATERIALS AND METHODS 
Peptides were synthesised on a SMPSA350 multiple peptide synthe- 
sis instrument utilising Fmoc chemistry (Zinsser Analytic, Maiden- 
head, UK). Purity was checked on reverse phase Cl& HPLC (Waters, 
Milford, USA). Sequence analysis was performed by Edman degrada- 
tion on an automated gas phase protein sequencer (Applied Biosys- 
terns, Warrington, UK). Mastoparan (Fespula lewisii) and pertussis 
toxin were purchased from Sigma Chemical Company, UK. Guanos- 
ine-5’-O-(3-thiotriphosphate) (GTPys) was obtained from Boehringer 
Mannheim, UK. Streptolysin-0 (SLO) was ordered from Wellcome 
Research, UK. 
Rat peritoneal mast cells were prepared and purified by published 
procedures 161. Experiments were performed at 30°C in the following 
buffer: 133 mM NaCl, 5 mM KCl, 0.9 mM NaH,PO,, 8 mM glucose, 
1 g/l BSA, 10 PM CaCI,, 20 mM HEPES at pH 7.4 set with NaOH. 
Secretory output of cell populations was determined by a sensitive 
assay for hexosaminidase nzyme activity [6]. This assay requires a 
fluorimetric substrate known as 4-methyl-umbelliferyl-2-acetamido-2- 
*Co~esponding author. Fax: (44) (223) 836614. 
deoxy-j&p-glucopyranoside obtained from Koch Light Laboratories, 
UK. Secretory output was also measured for histamine and heparin 
(data not shown); al1 three assays have reported similar qualitative 
changes in this work. Cellular cyclic 3’5’ AMP ~n~nt~tions were 
measured with a kit obtained from Amersham, UK. Changes in intra- 
cellular free calcium ion concentration [Ca”] were calculated from 
fura2-loaded mast cells using quantitative fluorescence ratio-imaging 
as described in [7]. 
3. RESULTS AND DISCUSSION 
3.1. rab3-Peptides timulate release from intact mast 
cells 
Our initial experiments ought to confirm previous 
findings that the authentic peptide sequence of rab3 
~S~GIDFKVKTIYRN), and a more potent two- 
amino acid substituted erivative rab3AL (VSALGID- 
FKVKTIYRN), induced secretion from streptolysin 0 
(SLO)-permeabilised cells [3,4]. We unexpectedly found 
that rab3AL stimulated secretory output from intact 
mast cells and that this effect was attenuated upon cell 
~~eabilisation (Fig. I), This finding was not due to 
the lack of ability of permeabilised cells to respond 
because an increase of 750% was observed with 10 PM 
GTPys (Fig. 1). rab3-like peptides behave like other 
polybasic compounds such as 48180 and mastoparan 
which trigger degranulation from intact mast cells but 
are less effective upon cell ~~eabilisation [X-lo]. 
3.2. Stimulation ofexocytosis is a speciJic action of rab3- 
like peptides 
To demonstrate that stimulation of secretion by a 
rab3-like peptide was a specific effect, we synthesised 
different peptides to equivalent regions of other small 
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GTP binding proteins, and to different regions of the 
rab3 class of proteins, and applied these to intact cells. 
We tested those peptides which have been previously 
used to show specificity of rab3 peptide [l]. Even when 
tested at the high concentration of 100 ,uM, only authen- 
tic rab3 and rab3AL were found to stimulate significant 
release of hexosaminidase (Fig. 2). rab3 had 60% of the 
activity associated with rab3AL, in agreement with pre- 
vious work [1,3]. Stimulation of release appeared to be 
specific to this region of rab3 because the corresponding 
aligned peptide sequences of rab2 and arf, and C-termi- 
nal domains for rab3a and rab3b, were without effect. 
A 5-mer peptide (VSALG) corresponding to the N- 
terminal end of rab3AL also had no effect (Fig. 2); and 
no response was found at a higher concentration of 400 
,uM (data not shown). These results were obtained by 
measuring the effects of various peptides on hexosam- 
inidase secretion from a population of mast cells but a 
similar profile of responses was also found for release 
of heparin and histamine (data not shown). Authentic 
rab3-peptide gives essentially the same experimental 
data as rab3AL but is less pronounced. For the purpose 
of clarity and brevity we only present data here for 
3,000 
Streptolysin-0 (units/ml) 
Fig. 1. Effect of rab3AL peptide, or GTPys, on secretion from mast 
cells exposed to various concentrations of streptolysin-0. A typical 
response to 100 PM rab3AL, or 10 ,uM GTPys. SLO was added for 
5 min prior to addition of peptide, or GTPys; 10 min later cells were 
pelleted and supematant was assayed for release of hexosaminidase 
[6]. Similar responses have been found in 3 other experiments. 
1,000 
Fig. 2. Effect of peptides derived from small GTP binding on hex- 
osaminidase release from intact mast cells. Each peptide was added 
at 1OOpM and their effect over 30 mitt on secretory output determined. 
For peptide sequences see [5]. ARF is a peptide sequence derived from 
ADP-ribosylation factor another small GTP-binding protein. VSALG 
is derived from the N-terminal end of rab3AL. Data is shown as the 
mean value f S.E.M. of a typical result of one of 4 separate xperi- 
ments. 
3.3. rab3AL stimulates exocytosis by activating a PtX- 
sensitive G protein 
To investigate whether a G protein might transduce 
the rab3AL-triggered degranulation event, mast cells 
were pretreated with PtX to inactivate heterotrimeric G 
proteins known to be vital for mast cell secretion in- 
duced by other polybasic agents such as mastoparan, 
48/80, and substance P [8-lo]. rab3AL had no effect on 
secretion from PtX-treated cells (Fig. 3A), and in addi- 
tion, PtX treatment blocked the ability of rab3AL to 
reduce cellular CAMP levels (Fig. 3B). Similar responses 
were found with mastoparan (Fig. 3A,B). Reduction of 
cellular CAMP levels by rab3AL and mastoparan indi- 
cates that both of these peptides may act via a G-protein 
of the Ga,, class which is linked to inhibition of adenyl- 
ate cyclase activity. PtX-sensitive G proteins activated 
by mastoparan are also linked to phospholipase C acti- 
vation and inositol 1,4,5 trisphosphate (IP3) production 
in mast cells [lo]. We have found that rab3AL stimu- 
lates a transient increase in the intracellular free calcium 
ion concentration in mast cells (Fig. 4); and this effect 
could be due to stimulation of IP3 production by 
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Fig. 3. Effect of 100pM rab3AL (RAB), or 10pM mastoparan (MP), 
on cells pre-treated with PtX (P. Toxin) (2pglml for 5 h). (A) secretory 
output of hexosaminidase was collected for 10 min. (B) cellular CAMP 
levels for part (A). Data were averaged from 6 separate xperiment 
and expressed as a % of their control value. Error bars are too small 
to depict in this histogram. 
rab3AL. However, recent evidence also suggests that 
there is an additional PtX-sensitive G protein which acts 
downstream of phospholipase C to trigger degranula- 
tion [l 11. Details about the nature of the PtX-sensitive 
G protein which could account for rab3AL-induced de- 
granulation remain to be established. 
3.4. rab3AL peptide has a structure andfinction similar 
to mastoparan 
Previous work has shown that mastoparan binds to 
phospholipid bilayers and causes a direct stimulation of 
Ga,,, activity [8,9]. Our data (Fig. 3) suggest that 
rab3AL might act in a similar manner. Alpha-helical 
wheel projections reveal striking structural similarities 
between the hydrophobic domains and charge distribu- 
tion of these two peptides (Fig. 5). This compelling 
structural (Fig. 5) and functional (Fig. 3) similarity sug- 
gest that signal transduction of rab3 peptide, like masto- 
paran, is probably due to a direct action on a PtX 
sensitive G-protein. Our data do not rule out the possi- 
bility that mast cells have a unique receptor on their cell 
surface to respond to rab3AL. But no specific cell-sur- 
face receptors have been found yet for other polybasic 
peptides on mast cells [lo]. Mastoparan does, however, 
bind directly to G proteins [9]. 
3.5. rab3AL is a polybasic peptide which can activate G 
proteins 
This paper clearly shows that externally applied 
rab3AL stimulates exocytosis from mast cells via a PtX- 
sensitive mechanism. A family of polybasic compounds 
like 48180, mastoparan, and substance P, appear to 
stimulate exocytosis from mast cells in manner similar 
to rab3AL; and so it was imperative to investigate 
whether the positive charged amino acids of rab3AL 
were important for activity. To investigate the effect of 
charge each lysine and arginine was systematically re- 
placed with the neutral amino acid residue alanine and 
the results are shown in Fig. 6. A marked reduction in 
activity was apparent when the C-terminal arginine res- 
idue was substituted with alanine. Complete loss of ac- 
tivity was obtained when a second alanine substitution 
was made for a lysine residue in position 11 of the linear 
sequence of rab3AL to produce a net neutral charged 
peptide (see Fig. 6). We conclude that basic amino acid 
residues are necessary to confer activity to rab3AL 
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Fig, 4. Effect of 100 PM rab3AL on changes in the intracellular free 
calcium ion concentration [Ca2’] measured by fura- and digital ratio- 
imaging [7]. Arrow marks addition of rab3AL to bath. 1.8 mM CaCI, 
was added to the medium prior to the experiment. Ca” transients have 
been recorded in 32/36 cells. 
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Fig. 5. Alpha-helical wheel projection for rab3AL and mastoparan (Mp). Bold type denotes hydrophobic amino acids. Positive charged residues 
are also marked (+). 
when applied extra~ll~arly, but hydrophobic residues 
might also have a function. This work does not distin- 
guish between the possibility that binding and effector 
parts of rab3AL are one of the same, or different. Fig. 
2 shows that VSALG has no effect on release from 
intact mast cells and lack of activity for this peptide has 
I- 3.6. Does regulation of a G protein by rab3AL explain 
other effects of this peptide? 
We previously reported a difference between the ef- 
fect of GTPyS and rab3AL on an in vitro membrane 
fusion assay (51. GTPyS stimulated membrane fusion of 
secretory granules to one another but rab3AL did not 
show this effect [5]. rab3AL, however, did stimulate 
membrane fusion between secretory granules and 
plasma membrane, an effect similar to that seen with 
GTPyS [S]. 
ii 
-I 
GDP/IS has been recently found to inhibit rab3AL 
stimulation of exocytotic rate in patch-clamped mela- 
notrophs (Rupnik, Zorec and Law, unpublished data). 
Upon guanine nucleotide exchange, the slowly hydroly- 
sable analog (GDP/%) is expected to bind to a GTP 
binding protein (monomeric or heterotrimeric) and to 
stabilise it in an inactive state. These findings are consis- 
tent with our hypothesis that one mechanism of action 
of rab3AL is mediated via regulation of a G-protein on 
the plasma membrane. 
Other experiments using patch-clamped mast cells 
found GDP~S-a~lerated degranulation to be stimu- 
lated by either rab3AL, or it’s truncated form VSALG 
[2]. The effect of GDPj?S is likely to be non-selective and 
cytosolic, where there is the potential to modify one or 
more GTP binding proteins. Glucagon activation of 
adenylate cyclase via a G protein is potentiated in the 
presence of GDP#& even though GDP/& inhibited the 
effect of a non-hydrolysable GTP analog [13]. GDP/IS 
can act as a partial agonist and in certain cases will 
support hormone-receptor mediated stimulation of a G 
1 5 25 100 
l’~l’T~DE CONCENTRATlON (PM) 
Fig. 6. Secretory response to charge neutralised erivatives of rab3AL. 
3ALt+ is normal rab3AL. 3AL’ has the arginine residue of rab3AL 
changed to alanine. 3AL’ has a second alanine substituted for the 
lysine in position 11 of the linear sequence of rab3AL. Data is ex- 
pressed as mean value + S.E.M. 
been recently confirmed in an in vitro membrane fusion 
assay that responds to rab3AL [12]. Both of these re- 
sults can be explained by a requirement for polybasic 
amino acids. VSALG triggered degranulation in patch- 
clamped mast cells [2] showing that fragments of 
rab3AL can have non-polybasic effects - a point dis- 
cussed below. 
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protein [13] and this activity may account for it’s effect 
reported in [2]. 
The accelerated response to GDPBS was however 
considered to be due to competition of rab3 peptides 
with endogenous rab3 proteins for a binding site on an 
unknown target effector protein [2]. However, patch- 
clamped mast cells were reported to respond to 
VSALG, VSTVG, ISTIG and ISALG nearly as well as 
rab3AL, calling into question the specificity of the rab3- 
like effect of 5-mer peptides. These 5-mer peptides have 
no net positive charge and their effects are clearly unre- 
lated to the one shown in Fig. 6, where charge is impor- 
tant for activity. Furthermore, VSALG has no effect on 
intact mast cells (Fig. 2) cell-free membrane fusion [12], 
and patch-clamped melanotrophs (data not shown). 
rab3AL may act on more than one GTP binding protein 
inside the cell as seems to be the case for mastoparan 
[8,14]. Stimulation of mast cell degranulation by a PtX- 
sensitive G protein is thus evidently required. Our ob- 
servation that rab3AL stimulates exocytotic release 
from mast cells via a PTX-sensitive G protein is consis- 
tent with other recent findings which report that 
rab3AL stimulates inositol 1,4,5trisphosphate produc- 
tion in pancreatic acini [ 151. Clearly evidence is accumu- 
lating to support the view that an isolated effector do- 
main of rab3 regulates heterotrimeric G proteins and 
possibly other downstream events. 
3.7. Conclusion 
This study demonstrates that rab3-like peptides stim- 
ulate exocytosis via a PtX-sensitive G protein when 
added to intact mast cells. This potent action of rab3AL 
is probably due to the well known property of polybasic 
peptides to directly regulate activity of G proteins. Data 
obtained with rab3-like peptides alone however is not 
sufficient to prove that a GTP-bound rab3 protein 
works by a similar mechanism, or is even restricted to 
such a mechanism. 
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